Clinical Trial Update: MK-0431 Early Phase II Double-blind Study - Type 2 Diabetes Mellitus (0431-043) [Phase 2]

View source ↗

Summary

This clinical trial update notes the completion of an early-phase Phase 2 double-blind study evaluating MK-0431 for Type 2 Diabetes Mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• MK-0431

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED